Skip to content

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06810375
Enrollment
120
Registered
2025-02-05
Start date
2025-03-01
Completion date
2029-02-28
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancers

Brief summary

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Interventions

preoperative erector spinae block with bupivacaine (Marcaine®)

intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)

Sponsors

George Washington University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Video assisted pulmonary resection, pleurodesis or decortication

Exclusion criteria

* Allergy to local anesthetics * Patient undergoing bilateral surgery * Surgery is emergent as deemed by the principal investigator

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain control assessmentUp to 48 hours postoperativelyStudy team will assess postoperative pain scores at 6, 12, 24 and 48 hours (Minimum numerical pain score of 0 and a maximum of 10)
Morphine equivalent assessmentUp to 72 hours postoperativelyStudy team will collect information on all administered pain medications to calculate morphine equivalents

Secondary

MeasureTime frameDescription
Postoperative pain control assessmentUp to 72 hours postoperativelyStudy team will assess postoperative pain scores at 72 hours (Minimum numerical pain score of 0 and a maximum of 10)

Countries

United States

Contacts

Primary ContactEduard Shaykhinurov, MS
eshaykhinurov@mfa.gwu.edu2022038960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026